Brain, Vol. 117, No. 3, 427-434, 1994
© 1994 Guarantors of Brain
research-article |
Human in vivo evidence for trigeminovascular activation in cluster headache Neuropeptide changes and effects of acute attacks therapies
1Department of Neurology, The Prince Henry Hospital Sydney, Australia 2Department of Internal Medicine, University Hospital of Lund Sweden
Correspondence to:
Correspondence to: Dr P. J. Goadsby, Department of Neurology, The Prince Henry Hospital, Little Bay Sydney, NSW 2036, Australia
Cluster headache is a rare very severe disorder that is clinically well characterized with a relatively poorly understood pathophysiology. In this study patients with episodic cluster headache fulfilling the criteria of the International Headache Society were examined during an acute spontaneous attack of headache to determine the local cranial release of neuropeptides. Blood was sampled from the external jugular vein ipsilateral to the pain before and after treatment of the attack. Samples were assayed for calcitonin gene-related peptide (CGRP), vasoactive intestinal polypeptide (VIP), substance P and neuropeptide Y. Attacks were treated with either oxygen inhalation, sumatriptan or an opiate. Thirteen patients were studied of whom 10 were male and three female. All had well-established typical attacks of cluster headache when blood was sampled. During the attacks external jugular vein blood levels of CGRP and VIP were raised while there was no change in neuropeptide Y or substance P. Calcitonin gene-related peptide levels rose to 110± 7 pmol/l (normal: <40) while VIP levels rose to 20 ± 3 pmol/l (normal: < 7). Treatment with both oyxgen and subcutaneous sumatriptan reduced the CGRP level to normal, while opiate administration did not alter the peptide levels. These data demonstrate for the first time in vivo human evidence for activation of the trigeminovascular system and the cranial parasympathetic nervous system in an acute attack of cluster headache. Furthermore, it is shown that both oxygen and sumatriptan abort the attacks and terminate activity in the trigeminovascular system.
calcitonin gene-related peptide; substance P; vasoactive intestinal polypeptide; neuropeptide Y; sumatriptan; oxygen
Received September 29, 1993. Revised December 16, 1993. Accepted January 24, 1994.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Recober, A. Kuburas, Z. Zhang, J. A. Wemmie, M. G. Anderson, and A. F. Russo Role of Calcitonin Gene-Related Peptide in Light-Aversive Behavior: Implications for Migraine J. Neurosci., July 8, 2009; 29(27): 8798 - 8804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Cittadini, M. S. Matharu, and P. J. Goadsby Paroxysmal hemicrania: a prospective clinical study of 31 cases Brain, April 1, 2008; 131(4): 1142 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Leone, A. Franzini, G. Broggi, E. Mea, A. P. Cecchini, and G. Bussone Acute hypothalamic stimulation and ongoing cluster headache attacks Neurology, November 28, 2006; 67(10): 1844 - 1845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Baumber, C. Sjostrand, M. Leone, H. Harty, G. Bussone, J. Hillert, R. C. Trembath, and M. B. Russell A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort Neurology, June 27, 2006; 66(12): 1888 - 1893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Leone, A. Franzini, G. Broggi, A. May, and G. Bussone Therapeutic stimulation of the hypothalamus: pathophysiological insights and prerequisites for management Brain, August 1, 2005; 128(8): E35 - E35. [Full Text] [PDF]
|
|
|
|
|
|
M. J. M. Fischer, S. Koulchitsky, and K. Messlinger The Nonpeptide Calcitonin Gene-Related Peptide Receptor Antagonist BIBN4096BS Lowers the Activity of Neurons with Meningeal Input in the Rat Spinal Trigeminal Nucleus J. Neurosci., June 22, 2005; 25(25): 5877 - 5883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P J Goadsby Trigeminal autonomic cephalalgias: fancy term or constructive change to the IHS classification? J. Neurol. Neurosurg. Psychiatry, March 1, 2005; 76(3): 301 - 305. [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Brain and A. D. Grant Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin Physiol Rev, July 1, 2004; 84(3): 903 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dux, P. Santha, and G. Jancso Capsaicin-sensitive neurogenic sensory vasodilatation in the dura mater of the rat J. Physiol., November 1, 2003; 552(3): 859 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. May Headache: lessons learned from functional imaging Br. Med. Bull., March 1, 2003; 65(1): 223 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Durham and A. F. Russo Stimulation of the Calcitonin Gene-Related Peptide Enhancer by Mitogen-Activated Protein Kinases and Repression by an Antimigraine Drug in Trigeminal Ganglia Neurons J. Neurosci., February 1, 2003; 23(3): 807 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Scorticati, G. Raina, and M. Federico Cluster-like headache associated to a foreign body in the maxillary sinus Neurology, August 27, 2002; 59(4): 643 - 643. [Full Text] [PDF]
|
|
|
|
|
|
P. J. Goadsby, K. L. Hoskin, R. J. Storer, L. Edvinsson, and H. E. Connor Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission Brain, June 1, 2002; 125(6): 1392 - 1401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. May, A. Bahra, C. Buchel, R. S. J. Frackowiak, and P. J. Goadsby PET and MRA findings in cluster headache and MRA in experimental pain Neurology, November 14, 2000; 55(9): 1328 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ashina, L. Bendtsen, R. Jensen, S. Schifter, I. Jansen-Olesen, and J. Olesen Plasma levels of calcitonin gene-related peptide in chronic tension-type headache Neurology, November 14, 2000; 55(9): 1335 - 1340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Durham and A. F. Russo Differential Regulation of Mitogen-Activated Protein Kinase-Responsive Genes by the Duration of a Calcium Signal Mol. Endocrinol., October 1, 2000; 14(10): 1570 - 1582. [Abstract] [Full Text]
|
|
|
|
|
|
A. Bahra, M. J. Gawel, J.-E. Hardebo, D. Millson, S. A. Breen, and P. J. Goadsby Oral zolmitriptan is effective in the acute treatment of cluster headache Neurology, May 9, 2000; 54(9): 1832 - 1839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. de la Sayette, S. Schaeffer, O. Coskun, F. Leproux, and G. Defer Cluster headache-like attack as an opening symptom of a unilateral infarction of the cervical cord: Persistent anaesthesia and dysaesthesia to cold stimuli J. Neurol. Neurosurg. Psychiatry, March 1, 1999; 66(3): 397 - 400. [Abstract] [Full Text]
|
|
|
|
|
|
J PASCUAL and J QUIJANO A case of chronic paroxysmal hemicrania responding to subcutaneous sumatriptan J. Neurol. Neurosurg. Psychiatry, September 1, 1998; 65(3): 407 - 407. [Full Text]
|
|
|
|
|
|
P. L. Durham and A. F. Russo Serotonergic Repression of Mitogen-Activated Protein Kinase Control of the Calcitonin Gene-Related Peptide Enhancer Mol. Endocrinol., July 1, 1998; 12(7): 1002 - 1009. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. Pourageaud and J. G. R. De Mey Vasomotor responses in chronically hyperperfused and hypoperfused rat mesenteric arteries Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1301 - H1307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Durham, R. V. Sharma, and A. F. Russo Repression of the Calcitonin Gene-Related Peptide Promoter by 5-HT1 Receptor Activation J. Neurosci., December 15, 1997; 17(24): 9545 - 9553. [Abstract] [Full Text] [PDF]
|
|